, Volume 192, Issue 4, pp 525–532

ADAM33 Gene Polymorphisms are Associated with the Risk of Idiopathic Pulmonary Fibrosis

  • Soo-Taek Uh
  • An-Soo Jang
  • Sung-Woo Park
  • Jong-Sook Park
  • Chang-Gi Min
  • Yong Hoon Kim
  • Byung-Lae Park
  • Hyoung Doo Shin
  • Dong Soon Kim
  • Choon-Sik Park



Idiopathic pulmonary fibrosis (IPF) is characterized by progressive dyspnea and worsening lung function due to remodeling of the lung, including epithelial mesenchymal transition. ADAM33 is a disintegrin and metalloprotease domain-containing protein, which may be related to lung fibrosis by exerting angiogenesis and remodeling of the lung. Thus, we evaluated the association of single-nucleotide polymorphisms (SNPs) of ADAM33 with the risk of IPF.


A total of 237 patients with IPF and 183 healthy subjects participated in the present study. Nine polymorphisms were selected. Genotyping was performed by single-base extension. Polymorphisms and haplotypes were analyzed for associations with the risk of IPF using multiple logistic regression models controlling for age, gender, and smoking status as covariates.


All SNPs were in Hardy-Weinberg equilibrium. The minor allele frequency (MAF) of rs628977G>A in intron 21 was significantly lower in subjects with surgical IPF than in normal controls in the recessive model [33.2 vs. 38.0 %, p = 0.02, OR = 0.40 (0.19–0.84)]. When the subjects with clinical IPF were included, the difference in MAF persisted with a p value of 0.03 [OR = 0.50 (0.27–0.94)].


ADAM33 rs628977G>A was marginally associated with a decreased risk of IPF in a recessive model.


ADAM33 Protein Single nucleotide polymorphisms Genotype Idiopathic pulmonary fibrosis 


  1. 1.
    Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824CrossRefPubMedGoogle Scholar
  2. 2.
    Loomis-King H, Flaherty KR, Moore BB (2013) Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis. Curr Opin Pharmacol 13:377–385PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    King TE Jr, Pardo A, Selman M (2011) Idiopathic pulmonary fibrosis. Lancet 378:1949–1961CrossRefPubMedGoogle Scholar
  4. 4.
    Gross TJ, Hunninghake GW (2001) Idiopathic pulmonary fibrosis. N Engl J Med 345:517–525CrossRefPubMedGoogle Scholar
  5. 5.
    Hodgson U, Laitinen T, Tukiainen P (2002) Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 57:338–342PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Marshall RP, Puddicombe A, Cookson WO, Laurent GJ (2000) Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 55:143–146PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Ward PA, Hunninghake GW (1998) Lung inflammation and fibrosis. Am J Respir Crit Care Med 157:S123–S129CrossRefPubMedGoogle Scholar
  8. 8.
    Gur I, Or R, Segel MJ, Shriki M, Izbicki G, Breuer R (2000) Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice. Exp Lung Res 26:521–534CrossRefPubMedGoogle Scholar
  9. 9.
    Oi M, Yamamoto T, Nishioka K (2004) Increased expression of TGF-beta1 in the sclerotic skin in bleomycin-‘susceptible’ mouse strains. J Med Dent Sci 51:7–17PubMedGoogle Scholar
  10. 10.
    Checa M, Ruiz V, Montano M, Velazquez-Cruz R, Selman M, Pardo A (2008) MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum Genet 124:465–472CrossRefPubMedGoogle Scholar
  11. 11.
    Mushiroda T, Wattanapokayakit S, Takahashi A, Nukiwa T, Kudoh S, Ogura T, Taniguchi H, Kubo M, Kamatani N, Nakamura Y (2008) A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet 45:654–656CrossRefPubMedGoogle Scholar
  12. 12.
    Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, Evans CM, Garantziotis S, Adler KB, Dickey BF, du Bois RM, Yang IV, Herron A, Kervitsky D, Talbert JL, Markin C, Park J, Crews AL, Slifer SH, Auerbach S, Roy MG, Lin J, Hennessy CE, Schwarz MI, Schwartz DA (2011) A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 364:1503–1512PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, Richards TJ, Silveira LJ, Lindell KO, Steele MP, Loyd JE, Gibson KF, Seibold MA, Brown KK, Talbert JL, Markin C, Kossen K, Seiwert SD, Murphy E, Noth I, Schwarz MI, Kaminski N, Schwartz DA (2013) Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 309:2232–2239PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Davies DE (2009) The role of the epithelium in airway remodeling in asthma. Proc Am Thorac Soc 6:678–682PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Black RA, White JM (1998) ADAMs: focus on the protease domain. Curr Opin Cell Biol 10:654–659CrossRefPubMedGoogle Scholar
  16. 16.
    Blobel CP (2000) Remarkable roles of proteolysis on and beyond the cell surface. Curr Opin Cell Biol 12:606–612CrossRefPubMedGoogle Scholar
  17. 17.
    Lee JH, Park HS, Park SW, Jang AS, Uh ST, Rhim T, Park CS, Hong SJ, Holgate ST, Holloway JW, Shin HD (2004) ADAM33 polymorphism: association with bronchial hyper-responsiveness in Korean asthmatics. Clin Exp Allergy 34:860–865CrossRefPubMedGoogle Scholar
  18. 18.
    Jongepier H, Boezen HM, Dijkstra A, Howard TD, Vonk JM, Koppelman GH, Zheng SL, Meyers DA, Bleecker ER, Postma DS (2004) Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 34:757–760CrossRefPubMedGoogle Scholar
  19. 19.
    van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Schouten JP, Boezen HM (2005) A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med 172:329–333CrossRefPubMedGoogle Scholar
  20. 20.
    Gosman MM, Boezen HM, van Diemen CC, Snoeck-Stroband JB, Lapperre TS, Hiemstra PS, Ten Hacken NH, Stolk J, Postma DS (2007) A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Thorax 62:242–247PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Lee JY, Park SW, Chang HK, Kim HY, Rhim T, Lee JH, Jang AS, Koh ES, Park CS (2006) A disintegrin and metalloproteinase 33 protein in patients with asthma: Relevance to airflow limitation. Am J Respir Crit Care Med 173:729–735CrossRefPubMedGoogle Scholar
  22. 22.
    Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, Bonsignore G (2003) Airway remodeling in asthma. Chest 123:417S–422SCrossRefPubMedGoogle Scholar
  23. 23.
    Jie Z, Jin M, Cai Y, Bai C, Shen Y, Yuan Z, Hu Y, Holgate S (2009) The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation. Respir Physiol Neurobiol 168:289–294CrossRefPubMedGoogle Scholar
  24. 24.
    American Thoracic Society; European Respiratory Society (2002) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS) and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277–304CrossRefGoogle Scholar
  25. 25.
    Katzenstein AL, Myers JL (1998) Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157:1301–1315CrossRefPubMedGoogle Scholar
  26. 26.
    Travis WD, Matsui K, Moss J, Ferrans VJ (2000) Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 24:19–33CrossRefPubMedGoogle Scholar
  27. 27.
    Ferris BG (1978) Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 118:1–120PubMedGoogle Scholar
  28. 28.
    Li M, Li C, Guan W (2008) Evaluation of coverage variation of SNP chips for genome-wide association studies. Eur J Hum Genet 16:635–643CrossRefPubMedGoogle Scholar
  29. 29.
    Shin HD, Park BL, Kim LH, Jung JH, Wang HJ, Kim YJ, Park HS, Hong SJ, Choi BW, Kim DJ, Park CS (2004) Association of tumor necrosis factor polymorphisms with asthma and serum total IgE. Hum Mol Genet 13:397–403CrossRefPubMedGoogle Scholar
  30. 30.
    Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, Jiang R, Messer CJ, Chew A, Han JH, Duan J, Carr JL, Lee MS, Koshy B, Kumar AM, Zhang G, Newell WR, Windemuth A, Xu C, Kalbfleisch TS, Shaner SL, Arnold K, Schulz V, Drysdale CM, Nandabalan K, Judson RS, Ruano G, Vovis GF (2001) Haplotype variation and linkage disequilibrium in 313 human genes. Science 293:489–493CrossRefPubMedGoogle Scholar
  31. 31.
    Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMedGoogle Scholar
  32. 32.
    Menashe I, Rosenberg PS, Chen BE (2008) PGA: power calculator for case-control genetic association analyses. BMC Genet 9:36PubMedCentralCrossRefPubMedGoogle Scholar
  33. 33.
    Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765–769PubMedCentralCrossRefPubMedGoogle Scholar
  34. 34.
    Yang Y, Wicks J, Haitchi HM, Powell RM, Manuyakorn W, Howarth PH, Holgate ST, Davies DE (2012) Regulation of a disintegrin and metalloprotease-33 expression by transforming growth factor-beta. Am J Respir Cell Mol Biol 46:633–640PubMedCentralCrossRefPubMedGoogle Scholar
  35. 35.
    Hanumegowda C, Farkas L, Kolb M (2012) Angiogenesis in pulmonary fibrosis: too much or not enough? Chest 142:200–207CrossRefPubMedGoogle Scholar
  36. 36.
    American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646–664CrossRefGoogle Scholar
  37. 37.
    Scientific Committee of the Korean Academy of Tuberculosis and Respiratory Diseases (2009) 2008 National Survey of Idiopathic Interstitial Pneumonia in Korea. Tuberc Respir Dis 66:141–151CrossRefGoogle Scholar
  38. 38.
    Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, Li K, Choi J, Vuga LJ, Lindell KO, Klesen M, Zhang Y, Gibson KF (2012) Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 185:67–76PubMedCentralCrossRefPubMedGoogle Scholar
  39. 39.
    Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G (2006) Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174:810–816CrossRefPubMedGoogle Scholar
  40. 40.
    Latsi P, Pantelidis P, Vassilakis D, Sato H, Welsh KI, du Bois RM (2003) Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis. Respir Res 4:6PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Selman M, Lin HM, Montano M, Jenkins AL, Estrada A, Lin Z, Wang G, DiAngelo SL, Guo X, Umstead TM, Lang CM, Pardo A, Phelps DS, Floros J (2003) Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 113:542–550CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Soo-Taek Uh
    • 1
  • An-Soo Jang
    • 2
  • Sung-Woo Park
    • 2
  • Jong-Sook Park
    • 2
  • Chang-Gi Min
    • 2
  • Yong Hoon Kim
    • 3
  • Byung-Lae Park
    • 4
  • Hyoung Doo Shin
    • 4
    • 5
  • Dong Soon Kim
    • 6
  • Choon-Sik Park
    • 2
    • 7
  1. 1.Division of Allergy and Respiratory MedicineSoonchunhyang University HospitalSeoulSouth Korea
  2. 2.Genome Research Center for Allergy and Respiratory DiseaseSoonchunhyang University Bucheon HospitalBucheonSouth Korea
  3. 3.Division of Respiratory MedicineSoonchunhyang UniversityChunanSouth Korea
  4. 4.Department of Genetic EpidemiologySNP-Genetics Inc.SeoulSouth Korea
  5. 5.Department of Life ScienceSogang UniversitySeoulSouth Korea
  6. 6.Division of Pulmonary and Critical Care Medicine, Asan Medical CenterUniversity of UlsanSeoulSouth Korea
  7. 7.Division of Allergy and Respiratory Medicine, Department of Internal MedicineSoonchunhyang University Bucheon HospitalBucheonSouth Korea

Personalised recommendations